Creative Biolabs Introduces List of Immune Cell Products to Expedite CAR-T Therapy Research
Jul 12, 2022
New York City, New York Jul 12, 2022 (Issuewire.com) - Over the past decade, CAR-T cell therapy, which enlists and strengthens the power of the human immune system to attack tumors, has rapidly become one of the key pillars of cancer treatment. With several drugs approved, CAR-T therapy has covered a wide range of cancer types, including acute lymphoblastic leukemia, B-cell lymphoma, follicular lymphoma, etc., and still shows potential in more diseases.
As a biopharmaceutical and basic research services provider, Creative Biolabs focuses on the development of CAR research, especially in areas of unmet need, and launches a comprehensive inventory of immune cell products to facilitate related research, including peripheral blood mononuclear cells (PBMCs), T cells, B cells, natural killer (NK) cells, monocytes, dendritic cells (DCs), neutrophils, control cells, and stem cells.
Featured Products:
- T cells: SLE CD4+ T Cells, Memory CD4+ Cells, T Regulatory Cells, CD8+ T Cells
- NK cells: Negatively Selected NK Cells
- DCs: Monocyte Derived Dendritic Cells
Creative Biolabs offers highly detailed certificates of analysis, product information, and collection parameter data in every order to ensure full transparency and product reliability. All products have been tested for cell counting, vitality, and function, and got purified and characterized by flow cytometry, as well as characterized by the FcRIII genotype. The expert team also offers a free consultation to make sure that the products match all requirements to make the most effective use of lab resources, time, and funds.
"The inventory management system, cryopreservation technology, and logistics solution ensure the products to be delivered with freshness and viability," said an expert at Creative Biolabs, "the years of experience contribute to the quality we're known for today. We take pride in serving services and products for research on CAR-T therapy, which has become trusted tools, accelerating the discovery of novel biological insights and helping researchers investigate what drives human health and disease."
Besides, being supported by a multidisciplinary team with flexible solutions, Creative Biolabs has developed a dedicated platform for clients to pre-design a custom CAR product. This platform is of visualization with a variety of choices for every detailed component such as CAR molecular construction, CAR vector, CAR cell, and CAR delivery.
More information can be reached at https://www.creative-biolabs.com/car-t/.
About Creative Biolabs
With years of exploration in biotechnology, Creative Biolabs has gathered talented scientists working closely with worldwide partners to develop and produce the medicines of tomorrow. Specifically, Creative Biolabs specializes in one-stop custom services for CAR-T therapy development, dendritic cell therapy development, TCR modified T cell development, CAR-macrophage therapy development, cancer vaccine development, etc.
Source :Creative Biolabs
This article was originally published by IssueWire. Read the original article here.
More News
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.